Advertisement

Ads Placeholder
Loading...

UCB SA

UCBJYPNK
Healthcare
Biotechnology
$159.36
$3.33(2.13%)
U.S. Market opens in 6h 41m

UCB SA (UCBJY) Stock Competitors & Peer Comparison

See (UCBJY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
UCBJY$153.08-1.38%58.3B32.99$4.64+0.52%
NONOF$35.59+1.22%158.1B10.05$3.54+4.15%
CSLLY$24.20-2.46%93.7B15.71$1.54+3.02%
UCBJF$305.36-4.62%58.1B32.91$9.28+0.52%
CMXHF$95.56-1.71%46.4B15.49$6.17+3.05%
ARGNF$712.03+0.00%44.1B36.36$19.58N/A
IVBXF$11.72+6.68%20.2B167.43$0.07N/A
WXIBF$4.60+0.00%19B27.06$0.17N/A
WXXWY$8.96+0.67%18.5B26.35$0.34N/A
GNMSF$265.00+0.00%16.3B17.24$15.37N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

UCBJY vs NONOF Comparison April 2026

UCBJY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UCBJY stands at 58.3B. In comparison, NONOF has a market cap of 158.1B. Regarding current trading prices, UCBJY is priced at $153.08, while NONOF trades at $35.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UCBJY currently has a P/E ratio of 32.99, whereas NONOF's P/E ratio is 10.05. In terms of profitability, UCBJY's ROE is +0.15%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, UCBJY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for UCBJY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions